MarketPeel
Insider Trading Intelligence
Pricing
…
MK

Maxwell Kirkby

GYRE
DIRECTOR · GYRE THERAPEUTICS, INC. · CIK 0002060862
FILING MIX · LIFETIME100%/0%
BUYS
1
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Aug 2026
HOLDINGS NOW
40,000
AVG SELL PX
—
TRADE KIND
SHOWING 1 / 1
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Maxwell Kirkby. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
Not enough transaction history to chart holdings.
Trading cadence · quarterly flow
BUY ● SELL ●
2026
FLOW · 1 buys / 0 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
GYRE
GYRE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
40,000——40,000Aug 3, 2026Aug 4, 2026 ↗View →
Other insiders · GYRE
Loading peer insiders…
About this filer
CIK 0002060862
ROLE
Director
PRIMARY
GYRE
COMPANIES
1
ACTIVE SINCE
Aug 2026
MARKETPEEL · /INSIDER/0002060862DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback